The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 15, 2024
Filed:
Apr. 02, 2021
Applicant:
Janssen Pharmaceuticals, Inc., Titusville, NJ (US);
Inventors:
Frederick E. Shelton, IV, Hillsboro, OH (US);
Monica A. Kapil, San Jose, CA (US);
Emma L. Hubert, San Jose, CA (US);
Jason L. Harris, Lebanon, OH (US);
Assignee:
Janssen Pharmaceuticals, Inc., Titusville, NJ (US);
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/00 (2006.01); A61B 5/0205 (2006.01); A61B 5/11 (2006.01); A61B 5/145 (2006.01); A61M 5/172 (2006.01); A61M 5/20 (2006.01); A61M 15/00 (2006.01); A61M 15/08 (2006.01); G16H 10/60 (2018.01); G16H 20/10 (2018.01); G16H 20/30 (2018.01); G16H 20/40 (2018.01); G16H 20/60 (2018.01); G16H 40/20 (2018.01); G16H 40/40 (2018.01); G16H 40/67 (2018.01); G16H 50/30 (2018.01); G16H 70/40 (2018.01); H04W 12/02 (2009.01); H04W 12/0431 (2021.01); A61B 5/021 (2006.01); A61B 5/024 (2006.01);
U.S. Cl.
CPC ...
A61B 5/4839 (2013.01); A61B 5/0022 (2013.01); A61B 5/02055 (2013.01); A61B 5/1101 (2013.01); A61B 5/1112 (2013.01); A61B 5/1118 (2013.01); A61B 5/14532 (2013.01); A61B 5/14542 (2013.01); A61B 5/4266 (2013.01); A61B 5/4866 (2013.01); A61M 5/1723 (2013.01); A61M 5/2033 (2013.01); A61M 15/0065 (2013.01); A61M 15/08 (2013.01); G16H 10/60 (2018.01); G16H 20/10 (2018.01); G16H 20/30 (2018.01); G16H 20/40 (2018.01); G16H 20/60 (2018.01); G16H 40/20 (2018.01); G16H 40/40 (2018.01); G16H 40/67 (2018.01); G16H 50/30 (2018.01); G16H 70/40 (2018.01); H04W 12/02 (2013.01); H04W 12/0431 (2021.01); A61B 5/021 (2013.01); A61B 5/024 (2013.01); A61B 2560/0242 (2013.01); A61M 2205/3317 (2013.01); A61M 2205/3327 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/505 (2013.01); A61M 2205/52 (2013.01); A61M 2230/04 (2013.01); A61M 2230/20 (2013.01); A61M 2230/201 (2013.01); A61M 2230/50 (2013.01); A61M 2230/63 (2013.01);
Abstract
In general, systems and methods for monitoring and communicating information using drug administration devices are provided.